Found 10 matching trials
Autologous CMV-Specific Cytotoxic T Cells and Temozolomide in Treating Patients With Glioblastoma
PHASE1This phase I/II trial studies the side effects and best dose of autologous ...
Location
M D Anderson Cancer Center
CMV-CTL for the Treatment of CMV Infection After HSCT
PHASE4Human cytomegalovirus (CMV) infection is a major cause of morbidity and mor...
Location
Shanghai Jiao Tong University Affilated Shanghai General Hospital
CD19 CAR T Cells for B Cell Malignancies After Allogeneic Transplant
PHASE1This phase I/II trial studies the safety and toxicity of post-transplant tr...
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Cytomegalovirus (CMV) Reactivation
PHASE2The goal of this clinical research study is to learn if giving cytotoxic T ...
Location
University of Texas MD Anderson Cancer Center
Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT
EARLY_PHASE1This trial studies the side effects and how well allogeneic cytomegalovirus...
Location
Nationwide Children's Hospital
Using Multi-virus Cytotoxic T-cells Following T-Cell Depleted Allogeneic HPCT for Prophylaxis Against EBV, ADV, and CMV
PHASE1This protocol is a phase I study. Patients may be eligible for an infusion ...
Location
Medical College of Wisconsin
Administration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma Multiforme
PHASE1Patients have a type of brain cancer called glioblastoma multiforme. Becaus...
Location
Texas Children's Hospital
Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)
PHASE2CMV cytotoxic T cells (CTLs) manufactured with the Miltenyi CliniMACS Prodi...
Location
Children's Hospital Los Angeles
ARMS - Rapidly Generated Multivirus-Specific CTLs for Prophylaxis & Treatment of EBV, CMV, Adenovirus, HHV6 & BK Virus
PHASE1The subjects eligible for this trial have a type of blood cell cancer, othe...
Location
Houston Methodist Hospital
Expanded Access Protocol of ATA230 (Third-Party Donor-Derived CMV-CTLs) for the Treatment of CMV Viremia or Disease
N/AThis is an expanded access protocol designed to provide access of ATA230 to...
Status
No Longer Available
Location
Multiple Locations